Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Normobaric Hyperoxia on Treatment Duration for Acute Ischemic Stroke Patients With Endovascular Treatment

NCT05404373 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT05404373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05404373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Normobaric Hyperoxia on Treatment Duration for Acute Ischemic Stroke Patients With Endovascular Treatment
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 20, 2022
Completion date
September 30, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular treatment, neuroprotection, stroke, acute